Trial intelligence / Profile preview

Efficacy of Ibuprofen/Acetaminophen Fixed-Dose Combination in Post-Surgical Dental Pain

NCT02912650Phase 3Completed

Sponsor
Pfizer
Start
Sep 2015
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ibuprofen and acetaminophen in postoperative pain (4 arms), sponsored by Pfizer. Primary endpoint: Time-weighted Sum of Pain Intensity Difference Scores on 11-Point Numerical Scale From 0 to 8 Hours Post-dose. Started Sep 2015; status: completed.

02

Drugs

ibuprofenacetaminophen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02912650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02912650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call